E-LIB Suche - Ergebnisse für: Pruis, Melinda A

1

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-..:

Pruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth...
The Oncologist. 28 (2023) 12 - p. e1248-e1258 , 2023

Link: https://doi.org/10.1093/..

2

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Ca..:

Pruis, Melinda A. ; Veerman, G.D. Marijn ; Hassing, H. Carlijne...
JACC: CardioOncology. 5 (2023) 1 - p. 102-113 , 2023

Link: https://doi.org/10.1016/..

3

Analysis of Serious Weight Gain in Patients Using Alectinib..:

de Leeuw, Simon P. ; Pruis, Melinda A. ; Sikkema, Barend J....
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1017-1030 , 2023

Link: https://doi.org/10.1016/..

4

Renal function-based versus standard dosing of pemetrexed: ..:

de Rouw, Nikki ; Boosman, René J. ; Burgers, Jacobus A....
Cancer Chemotherapy and Pharmacology. 91 (2022) 1 - p. 33-42 , 2022

Link: https://doi.org/10.1007/..

5

Personalised selection of experimental treatment in patient..:

Pruis, Melinda A. ; Groenendijk, Floris H. ; Badloe, K. Sangeeta...
British Journal of Cancer. 127 (2022) 4 - p. 776-783 , 2022

Link: https://doi.org/10.1038/..

6

A phase 1 open-label study to assess the relative bioavaila..:

Steeghs, Neeltje ; Pruis, Melinda ; van Herpen, Carla...
Investigational New Drugs. 41 (2022) 1 - p. 53-59 , 2022

Link: https://doi.org/10.1007/..

7

Plasma Predictive Features in Treating EGFR-Mutated Non-Sma..:

Steendam, Christi M. J. ; Veerman, G. D. Marijn ; Pruis, Melinda A....
Cancers. 12 (2020) 11 - p. 3179 , 2020

Link: https://doi.org/10.3390/..

8

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-..:

Pruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth...
Pruis , M A , Krebs , M G , Plummer , R , De Vos , F , Angevin , E , Prenen , H , Forster , M D , Clack , G , Van der Aa , A , Tjwa , M , Jansen , E , Perera , T & Lolkema , M P 2023 , ' A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer ' , The oncologist . https://doi.org/10.1093/oncolo/oyad146. , 2023

Link: https://research.manches..

9

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-..:

Pruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth...
https://discovery.ucl.ac.uk/id/eprint/10173852/1/oyad146.pdf. , 2023

Link: https://discovery.ucl.ac..

10

Personalised selection of experimental treatment in patient..:

Pruis, Melinda A ; Groenendijk, Floris H ; Badloe, K. Sangeeta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381598/. , 2022

Link: http://www.ncbi.nlm.nih...

11

A phase 1 open-label study to assess the relative bioavaila..:

Steeghs, Neeltje ; Pruis, Melinda ; van Herpen, Carla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030390/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Plasma Predictive Features in Treating EGFR-Mutated Non-Sma..:

Steendam, Christi M. J ; Veerman, G. D. Marijn ; Pruis, Melinda A...
Steendam , C M J , Veerman , G D M , Pruis , M A , Atmodimedjo , P , Paats , M S , van der Leest , C , von der Thusen , J H , Yick , D C Y , Oomen-de Hoop , E , Koolen , S L W , Dinjens , W N M , van Schaik , R H N , Mathijssen , R H J , Aerts , J G J V , Dubbink , H J & Dingemans , A-M C 2020 , ' Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer ' , Cancers , vol. 12 , no. 11 , 3179 . https://doi.org/10.3390/cancers12113179. , 2020

Link: https://cris.maastrichtu..

13

Plasma predictive features in treating egfr-mutated non-sma..:

Steendam, Christi ; Veerman, Marijn ; Pruis, Melinda...
Steendam , C , Veerman , M , Pruis , M , Atmodimedjo , P , Paats , M , van der Leest , C , von der Thüsen , J , Yick , DCY , Oomen - de Hoop , E , Koolen , S , Dinjens , W , van Schaik , R , Mathijssen , R , Aerts , J , Dubbink , E J & Dingemans , AMA 2020 , ' Plasma predictive features in treating egfr-mutated non-small cell lung cancer ' , Cancers , vol. 12 , no. 11 , 3179 , pp. 1-17 . https://doi.org/10.3390/cancers12113179. , 2020

Link: https://pure.eur.nl/en/p..

14

Plasma Predictive Features in Treating EGFR-Mutated Non-Sma..:

Christi M. J. Steendam ; G. D. Marijn Veerman ; Melinda A. Pruis...
https://www.mdpi.com/2072-6694/12/11/3179. , 2020

Link: https://doi.org/10.3390/..

15

Plasma Predictive Features in Treating EGFR-Mutated Non-Sma..:

Christi M. J. Steendam ; G. D. Marijn Veerman ; Melinda A. Pruis...
Molecular Cancer Biology. , 2020

Link: https://doi.org/10.3390/..